Vol. 66, 2024 > Iss. 1, June
JRM Cover
  • Orignal article

Hormonal Contraceptive Use and Risk of Recurrent Vaginitis: Towards Understanding Microbial and Clinical Interactions
Vol. 66, 2024 - Iss. 1, June

Authors: John Alex1, Anton Andrej1
1University of Ljubljana

Abstract

Recurrent vaginitis remains a significant clinical challenge, with inconsistent definitions and multifactorial etiologies. Emerging evidence suggests a potential link between hormonal contraceptive use and increased recurrence rates, particularly in the context of Mycoplasma and Ureaplasma infections. This paper reviews existing literature, presents new hypotheses on the mechanisms of hormonal influence on the vaginal microbiome, and outlines directions for clinical management and future research.

Keywords: mycoplasma, ureaplasma, multifactorial etiologies, vaginal microbiome

References

  1. Ara I, Maqbool M, Gani I. Reproductive Health of Women: implications and attributes. International Journal of Current Research in Physiology and Pharmacology. 2022 Nov 28:8-18.
  2. Davidson PM, McGrath SJ, Meleis AI, Stern P, DiGiacomo M, Dharmendra T, Correa-de-Araujo R, Campbell JC, Hochleitner M, Messias DK, Brown H. The health of women and girls determines the health and well-being of our modern world: A white paper from the International Council on Women’s Health Issues. Health Care for Women International. 2011 Oct 1;32(10):870-86.
  3. Glasier A, Gülmezoglu AM, Schmid GP, Moreno CG, Van Look PF. Sexual and reproductive health: a matter of life and death. The Lancet. 2006 Nov 4;368(9547):1595-607.
  4. Lynch JW, Kaplan GA, Shema SJ. Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. New England Journal of Medicine. 1997 Dec 25;337(26):1889-95.
  5. Alex J, Andrej A. Comparative efficacy and safety of radial and femoral access for percutaneous coronary intervention (PCI) in the context of novel antithrombotic regimens and device innovations: A 2022 update. Journal of Rare Cardiovascular Disease. 2022;4(6):127-32.
  6. Sobel JD. Recurrent vulvovaginal candidiasis. New England Journal of Medicine. 1986 Dec 4;315(23):1455-8.
  7. Marrazzo JM, Thomas KK, Fiedler TL, Ringwood K, Fredricks DN. Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study. PloS one. 2010 Jun 15;5(6):e11139.
  8. Gollub EL, Cyrus E, Devieux JG, Jean-Gilles M, Neptune S, Pelletier V. Cervical Barriers Bibliography. African Journal Reproductive Health. 2014;18:77-86.
  9. Zalán Z, Németh E, Baráth Á, Halász A. Influence of growth medium on hydrogen peroxide and bacteriocin production of Lactobacillus strains. Food technology and Biotechnology. 2005 Sep 15;43(3):219-25.
  10. Thomas CJ, Schroder K. Pattern recognition receptor function in neutrophils. Trends in Immunology. 2013 Jul 1;34(7):317-28.
  11. Amin M, Tang S, Shalamanova L, Taylor RL, Wylie S, Abdullah BM, Whitehead KA. Polyamine biomarkers as indicators of human disease. Biomarkers. 2021 Feb 17;26(2):77-94.
  12. Doneza JA, Dabney L. Vaginitis, cervicitis, and pelvic inflammatory disease. Obstetrics and Gynecology. 2020 Aug 12:143-51.
  13. Colautti A, Orecchia E, Comi G, Iacumin L. Lactobacilli, a weapon to counteract pathogens through the inhibition of their virulence factors. Journal of Bacteriology. 2022 Nov 15;204(11):e00272-22.
  14. Nguyen J, Lara-Gutiérrez J, Stocker R. Environmental fluctuations and their effects on microbial communities, populations and individuals. FEMS Microbiology Reviews. 2021 Jul;45(4):fuaa068.
  15. Leary DJ, Rip JM, Petchey OL. The impact of environmental variability and species composition on the stability of experimental microbial populations and communities. Oikos. 2012 Mar;121(3):327-36.
  16. Sanders JN, Turok DK, Royer PA, Thompson IS, Gawron LM, Storck KE. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception. Contraception. 2017 Aug 1;96(2):99-105.
  17. Alex J. IVF in the United States: Market Innovation and Social Inequality in Reproductive Healthcare. Journal of Reproductive Medicine. 2022;64(1):1-6.
  18. Kumari S, Sarkar A, Kulshreshtha A, Zangmo R, Roy KK. Exploring the role of levonorgestrel intrauterine system (LNG-IUS) as a method of emergency contraception (EC). Cureus. 2022 Nov 28;14(11).
  19. Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013 Aug 7;347.
  20. Amabebe E, Anumba DO. The vaginal microenvironment: the physiologic role of lactobacilli. Frontiers in Medicine. 2018 Jun 13;5:181.
  21. Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cellular microbiology. 2014 Jul;16(7):1024-33.
  22. Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Research in Microbiology. 2017 Nov 1;168(9-10):875-81.
  23. Beaudet JA. Global transcriptional analysis of the chicken tracheal response to virulent and attenuated vaccine strains of Mycoplasma gallisepticum. University of Connecticut; 2017.
  24. Barańska A, Dolar-Szczasny J, Kanadys W, Kinik W, Ceglarska D, Religioni U, Rejdak R. Oral contraceptive use and breast cancer risk according to molecular subtypes status: a systematic review and meta-analysis of case-control studies. Cancers. 2022 Jan 23;14(3):574.
  25. Agenor M, Perez AE, Wilhoit A, Almeda F, Charlton BM, Evans ML, Borrero S, Austin SB. Contraceptive care disparities among sexual orientation identity and racial/ethnic subgroups of US women: a national probability sample study. Journal of Women’s Health. 2021 Oct 1;30(10):1406-15.